StereotaxisNot yet claimed

About Stereotaxis

Stereotaxis is the pioneer of Robotic Magnetic Navigation (RMN), a surgical robotics approach in which computer-controlled magnetic fields, generated by magnets on robotic arms beside the operating table, steer the tips of magnetic catheters and guidewires through the blood vessels and chambers of the heart. Its systems are used by electrophysiologists for catheter ablation and other minimally invasive endovascular procedures to treat arrhythmias, and the company states its technology has been used to treat more than 150,000 patients in the United States, Europe, Asia and elsewhere (company-stated). The current platform line-up is led by the Genesis RMN system and the newer GenesisX system, which received FDA approval in November 2025, together with the company’s own MAGiC robotically navigated magnetic ablation catheter (CE marked in Europe in 2025 and FDA approved in January 2026), navigation software and catheter-advancement components.

Stereotaxis is also expanding through imaging partnerships — including a 2026 compatibility collaboration with a major interventional X-ray platform — and in April 2026 it agreed to acquire Robocath, a French developer of robotics for interventional cardiology and neurointervention. The company works with hospitals that run electrophysiology and interventional labs and sells systems, disposables and service.

Products & services

• Genesis RMN and GenesisX Robotic Magnetic Navigation systems
• MAGiC robotically navigated magnetic ablation catheter
• Navigant catheter navigation software and Cardiodrive catheter advancement system
• Integrated interventional lab solutions, including imaging compatibility with third-party angiography platforms
• Recurring disposables, service and support for the installed base

Questions partners ask

GlobleMatch Trust Signals

A directory that doesn’t sell stars. Trust Signals are built only from verifiable facts — never from anonymous ratings, and never for sale. There is no single hidden score.

Public information coverage	8 of 9 fields on the standard profile could be filled from public sources. This counts how much public information exists about the company — not how good the company is. The nine fields are listed in the methodology. Claiming the profile lets the company complete the remaining fields itself.
Last verified	6 November 2026 — facts on this profile were checked against the sources listed below. Profiles are re-checked on a published 90-day cycle; this date is never quietly refreshed.

Claim this profile to unlock response record, directory tenure and peer endorsements. The full methodology — what each signal measures and how it is calculated — is published in the Trust Signals methodology, including a change log.

Sources & verification

• Company website — stereotaxis.com (official site: profile facts, headquarters, markets and product range). Checked 6 November 2026.
• Figures described in this profile as company-stated come from the company’s own public materials and were not independently audited by GlobleMatch.

Facts last verified: 6 November 2026. Something wrong? A listed company can request a correction or removal at any time; verified requests are actioned.

Related companies

More in Robotics & hardware: Ekso Bionics (medical exoskeletons for rehabilitation and personal mobility, United States) · Lifeward (wearable exoskeletons and anti-gravity therapy systems, United States) · SS Innovations (robotic-assisted minimally invasive surgery systems, India)

Robotics on GlobleMatch: the GlobleMatch Robotics 100 programme tracks leading robotics companies worldwide, and claimed directory profiles can be considered for its seats.